Our ESR12 defended her Doctoral Thesis: Evaluation of genetic polymorphisms associated with the metabolic effects of olanzapine and aripiprazole

Training School 3 and Consortium Meeting take place in Coimbra, Portugal

Ángela M. Valverde, coordinator of TREATMENT, took part in the videoconference organized by MSD and CIBERDEM

Ángela M. Valverde, coordinator of ITN TREATMENT and member of CIBERDEM, took part in the videoconference organized by MSD (Merck Sharp & Dohme) and CIBERDEM (spanish network of diabetes and metabolic diseases) as moderator

ESRs of ITN TREATMENT attended the School 2 & MTR in Jerusalem

TREATMENT Mid-Term Review TREATMENT School 2: The epidemic of fatty liver diseases: risk factors, treatment and extrahepatic consequences 20th November, 2018 Session I: TREATMENT Mid-Term Review (Part I) 9:00-9:15 Short introduction by the REA Project Officer, the External expert and […]

ITN TREATMENT promotional video

Ángela M. Valverde, coordinator of ITN TREATMENT, took part in a round table for the Diabetes Day

Sangeetha Bupalan, ESR15 of ITN TREATMENT, participated in the ReelLIFE Science 2018

Ángela M. Valverde, coordinator of ITN TREATMENT, was interviewed

ESR1, ESR9 and ESR11 on Secondment

Ángela Valverde, coordinator of ITN TREATMENT, at EASD 2018 in Berlín

ITN TREATMENT at the 9th European Researchers Night in Ljubljana

ITN TREATMENT at the 9th European Researchers Night in Madrid

Ángela M. Valderde, coordinator of ITNTREATMENT, at the Annual Conference of ciberdem

Ángela M. Valverde, coordinator of ITN TREATMENT, attended the Annual Conference of ciderdem, 2018. Dr. Valverde and her team showed the latest results of their investigations. You can find more information in the following link.

Paloma Sánchez Aparicio, Project Manager of ITNTREATMENT, attended a Science Communication Course

Successful 5th Symposium on Biomedical Research

We put the focus on drug induced metabolic dysfunctions